Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech

All NewsMarch 29, 2026

Global pharmaceutical companies are aggressively searching for new medicines in China

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent